Peer-reviewed study finds Russia's COVID vaccine is 91.6% effective
Published
Some experts say The Lancet study, based on data from a large-scale human trial in Moscow, should end skepticism over the vaccine.
Full ArticlePublished
Some experts say The Lancet study, based on data from a large-scale human trial in Moscow, should end skepticism over the vaccine.
Full ArticleBy Hafed Al-Ghwell*
According to estimates by the International Monetary Fund (IMF), the Middle East will begin to..
Pfizer's COVID-19 vaccine was 94% effective against symptomatic coronavirus, a week after the second dose. This compared to 95% in..